Skip to content

Study on Exercise Rehabilitation Intervention in Chronic Stroke Patients with Hemiplegia

Study on Exercise Rehabilitation Intervention in Chronic Stroke Patients with Hemiplegia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041335
Enrollment
Unknown
Registered
2020-12-23
Start date
2020-12-12
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

intervention group:Exercise intervention + routine rehabilitation
control group:routine rehabilitation

Sponsors

Huashan Hospital affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged from 18 to 80 years, regardless of gender; 2. Patients whose onset time can be more than 6 months are diagnosed as ischemic stroke or hemorrhagic stroke by imaging; 3. In hemiplegic patients, there was no dysfunction on the contralateral side; 4. The subjects with stable vital signs had good blood pressure control below 150/90 mmHg, oxygen saturation > 92%, resting heart rate of 40-100 BPM and body temperature not higher than 37 degrees C. they could take exercise with the consent of the attending physician; 5. Subjects who understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with serious heart disease, who may be at risk due to exercise; 2. Patients with multiple cerebral infarction (more than 3 times); 3. Patients with poor cognitive level can not understand the movement guidance of rehabilitation therapists; 4. The patients with disability on the contralateral limb can not exercise normally; 5. Patients with arthritis, such as postoperative, affect the patient's exercise; 6. Patients who participated in other clinical trials; 7. Pregnant subjects; 8. Patients with heart failure, respiratory failure, liver and kidney insufficiency, hematological diseases, malignant tumor, etc.

Design outcomes

Primary

MeasureTime frame
ADL;

Countries

China

Contacts

Public ContactJia Jie

Huashan Hospital affiliated to Fudan University

shannonjj@126.com+86 13611722357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026